Futura Medical (GYX) Stock Statistics & Valuation Metrics
Total Valuation
Futura Medical has a market cap or net worth of EUR 3.29M. The enterprise value is EUR 1.78M.
- Market Cap
- EUR 3.29M
- Enterprise Value
- EUR 1.78M
Share Statistics
Futura Medical has 1,482,327,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,482,327,800
- Owned by Insiders
- 7.58%
- Owned by Institutions
- <0.01%
Financial Efficiency
Futura Medical’s return on equity (ROE) is -3.23 and return on invested capital (ROIC) is -180.43%.
- Return on Equity (ROE)
- -3.23
- Return on Assets (ROA)
- -1.74
- Return on Invested Capital (ROIC)
- -180.43%
- Return on Capital Employed (ROCE)
- -1.86
- Revenue Per Employee
- 121.19K
- Profits Per Employee
- -647.91K
- Employee Count
- 14
- Asset Turnover
- 0.33
- Inventory Turnover
- 1756.57
Valuation Ratios
The current PE Ratio of Futura Medical is -0.30. Futura Medical’s PEG ratio is -0.01.
- PE Ratio
- -0.30
- PS Ratio
- 0.28
- PB Ratio
- 0.55
- Price to FCF
- -0.13
- Price to Operating Cash Flow
- -0.23
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Futura Medical had revenue of 1.70M and earned -9.07M in profits. Earnings per share was -0.03.
- Revenue
- 1.70M
- Gross Profit
- 1.24M
- Operating Income
- -5.66M
- Pretax Income
- -9.33M
- Net Income
- -9.07M
- EBITDA
- -5.54M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -4.79M and capital expenditures 0, giving a free cash flow of -4.79M billion.
- Operating Cash Flow
- -4.79M
- Free Cash Flow
- -4.79M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Futura Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -743.42%
- Earnings Yield
- -331.90%
Stock Price Statistics
- Beta
- 1.39
- 52-Week Price Change
- -87.50%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Futura Medical upcoming earnings date is Apr 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 01, 2026
- Next Earnings Date
- Apr 14, 2027
- Ex-Dividend Date
- ―
Financial Position
Futura Medical as a current ratio of 2.06, with Debt / Equity ratio of 0.00%
- Current Ratio
- 2.06
- Quick Ratio
- 2.06
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.61
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Futura Medical has paid -255.00K in taxes.
- Income Tax
- -255.00K
- Effective Tax Rate
- 0.03
Enterprise Valuation
Futura Medical EV to EBITDA ratio is 3.93, with an EV/FCF ratio of 0.13.
- EV to Sales
- -0.26
- EV to EBITDA
- 3.93
- EV to Free Cash Flow
- 0.13
- EV to Operating Cash Flow
- 0.13
Balance Sheet
Futura Medical has EUR 1.24M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 1.24M billion.
- Cash & Marketable Securities
- EUR 1.24M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 1.24M
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 110.59%, with operating margin of -9.93%, and net profit margin of -158.21%.
- Gross Margin
- 110.59%
- Operating Margin
- -9.93%
- Pretax Margin
- -164.90%
- Net Profit Margin
- -158.21%
- EBITDA Margin
- -6.58%
- EBIT Margin
- -11.58%
Analyst Forecast
The average price target for Futura Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -71.75%
- EPS Growth Forecast
- 61.79%
